Research highlights of clinical oncology early 2022

Advance in clinical oncology is highly relied on development of cancer research and clinical trials. There has been ample evidence regarding the new therapeutic drugs, agents or techniques for the treatment of cancer. We did a broad literature search to catch the latest progress in the cancer therap...

Descripción completa

Detalles Bibliográficos
Autor principal: Wu, Kaichun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255546/
https://www.ncbi.nlm.nih.gov/pubmed/37520335
http://dx.doi.org/10.1007/s44178-022-00006-9
_version_ 1784740943652454400
author Wu, Kaichun
author_facet Wu, Kaichun
author_sort Wu, Kaichun
collection PubMed
description Advance in clinical oncology is highly relied on development of cancer research and clinical trials. There has been ample evidence regarding the new therapeutic drugs, agents or techniques for the treatment of cancer. We did a broad literature search to catch the latest progress in the cancer therapy. Here is a brief review of the newly released results of clinical trials including surgical modalities, immune checkpoint blockade, chimeric antigen receptor T-cell (CAR T) therapy, antibody–drug conjugates and tumor vaccines, etc. Biomarkers or patient assessment of cancer therapy were also discussed.
format Online
Article
Text
id pubmed-9255546
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Nature Singapore
record_format MEDLINE/PubMed
spelling pubmed-92555462022-07-06 Research highlights of clinical oncology early 2022 Wu, Kaichun Holist Integ Oncol Review Advance in clinical oncology is highly relied on development of cancer research and clinical trials. There has been ample evidence regarding the new therapeutic drugs, agents or techniques for the treatment of cancer. We did a broad literature search to catch the latest progress in the cancer therapy. Here is a brief review of the newly released results of clinical trials including surgical modalities, immune checkpoint blockade, chimeric antigen receptor T-cell (CAR T) therapy, antibody–drug conjugates and tumor vaccines, etc. Biomarkers or patient assessment of cancer therapy were also discussed. Springer Nature Singapore 2022-07-05 2022 /pmc/articles/PMC9255546/ /pubmed/37520335 http://dx.doi.org/10.1007/s44178-022-00006-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review
Wu, Kaichun
Research highlights of clinical oncology early 2022
title Research highlights of clinical oncology early 2022
title_full Research highlights of clinical oncology early 2022
title_fullStr Research highlights of clinical oncology early 2022
title_full_unstemmed Research highlights of clinical oncology early 2022
title_short Research highlights of clinical oncology early 2022
title_sort research highlights of clinical oncology early 2022
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255546/
https://www.ncbi.nlm.nih.gov/pubmed/37520335
http://dx.doi.org/10.1007/s44178-022-00006-9
work_keys_str_mv AT wukaichun researchhighlightsofclinicaloncologyearly2022

Ejemplares similares